Pharmaceutical Caps and Closures Market to surpass US$ 2.27 Bn in valuation by the end of 2021

According to Future Market Insights (FMI), the demand for Pharmaceutical Caps and Closures is expected to rise considerably, enabling the market to surpass US$ 2.27 Bn in valuation by the end of 2021.

Continuous advancements in research and development for drug supplements is a key factor speeding up packaging innovations. Advanced technologies used in packaging primarily focus on ensuring stability of drugs during storage, shipment, and delivery.

In the coming years, the rising cases of chronic disease will support the expansion of the market. The role of smart packaging for medication is increasing to offer greater precision of administered medication, which directly affects patient compliance. This will influence the adoption of cost-effective yet advanced packaging solutions among manufacturers.

The pharmaceutical caps and closures market will therefore register adoption of digital manufacturing. This technology offers high quality caps and closure, with minimal time and cost requirements.

Focus on reducing product damage by user has encouraged inventors to introduce multi-dose delivery caps. The product’s user can remove fluid from the vial by interfacing a needle to the cap. The smart cap ensures that leftover fluid is clean.

In the past few years, environmental awareness among consumers has increased the need for sustainable packaging. In pharmaceutical packaging, the primary concern is product stability.

The demand for reducing the risk of cross contamination of product drives the use of biodegradable material in caps and closures. Also, waste product management is a key concern. Environmentally-friendly material produce lesser waste and are also recyclable.

Despite this, plastics remain the preferred material for manufacturing caps and closures. Plastic use in the market is expected to rise at 6.4% as producers aim for greater flexibility.

To remain ‘ahead’ of your competitors, request for a sample-

Key Takeaways from Pharmaceutical caps and closures Services Market Study

  • Despite restricted growth amid COVID-19, the demand for pharmaceutical caps and closures is expected to rise at nearly 5% CAGR in 2021.
  • Increasing focus on light weight packaging is driving a transition towards resin-based packaging material.
  • The U.K. and Germany are leading markets in Europe, accounting for more than 26% and 17% of the Europe market respectively in 2021
  • The U.S. will account for a dominant share of 89% in the North America market through the forecast period.
  • China is the largest and fastest growing market in East Asia, exhibiting 8% CAGR through 2031.

“Increasing demand for smart and safe packaging solutions for pharmaceuticals, besides favorable reimbursement policies will offer lucrative growth opportunities for pharmaceutical caps and closure manufacturers through the assessment period in 2031,” says the FMI analyst.

Increase in Funding for Research Activities Offers Growth Opportunities

Leading manufacturers in the pharmaceutical caps and closures market are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research pharmaceutical packaging products.

For instance, Voltaren “No Mess” applicator from GSK Consumer Health was co-developed with Neopac and Nypro Healthcare.

Big drug producers are expected to benefit from the globalization of labor forces, that is, employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Get a Customized Scope to Match Your Need Ask an Expert-

Who is winning?

The global market is set to expand due to the rising prevalence of chronic diseases. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.

Some of the leading players in the pharmaceutical caps and closures market include but are not limited to Berry Global Inc., Amcor Plc, Aptar Inc., Closure Systems International Inc., O.Berk Company LLC, Bericap GmbH and Co KG, UNITED CAPS, CL Smith Company, Georg MENSHEN GmbH & Co. KG, WestRock Company, West Pharmaceutical Services Inc., Drug Plastics and Glass Co Inc., Gerresheimer AG, DWK Life Sciences GmbH, Parekhplast India Limited, and Parshva Exim Limited.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:

Leave a comment

Your email address will not be published. Required fields are marked *